Person

Back to overview

Bourquin Carole

Gender Female
Institute School of Pharmaceutical Sciences University of Geneva
ORCID 0000-0003-3862-4583
Show all

Projects as responsible applicant

Responsible applicant Institution of higher education Start End date Funding scheme

ProDoc Cell Migration Research Module 3: Soluble factors in Cell Migration
Bourquin Carole University of Fribourg - FR 01.10.2012 31.10.2016 ProDoc

Gasotransmitters in triple negative breast cancer (full proposal)
Bourquin Carole University of Geneva - GE 01.09.2021 31.08.2023 SPIRIT

HMGB1 and Gasdermin D: intratumoral targets to improve the response to cancer immunotherapy
Bourquin Carole University of Geneva - GE 01.01.2019 31.12.2022 Project funding (Div. I-III)

RLR/TLR combination therapy: Mechanisms of T-cell recruitment into gastric tumors
Bourquin Carole University of Fribourg - FR 01.06.2015 31.12.2018 Project funding (Div. I-III)

Understanding the interaction of nanoparticles with B lymphocytes in vitro and in vivo
Bourquin Carole University of Fribourg - FR 01.02.2015 31.12.2018 Project funding (Div. I-III)

Immunotherapy of gastric cancer: Enhancing T cell recruitment into tumors
Bourquin Carole University of Fribourg - FR 01.01.2012 31.05.2015 Project funding (Div. I-III)

Projects as co-applicant

Responsible applicant Institution of higher education Start End date Funding scheme

Cell Migration
Wolf Marlene University of Berne - BE 01.09.2011 31.10.2016 ProDoc

Cell migration in tumorigenesis and metastasis
Rüegg Curzio Roberto University of Fribourg - FR 01.01.2012 29.02.2016 ProDoc

NCCR Bio-Inspired Materials: Center for Bio-Inspired Stimuli-Responsive Materials (phase I)
Weder Christoph University of Fribourg - FR 01.06.2014 31.05.2018 National Centres of Competence in Research (NCCRs)

Microchip-based flow cell sorting in biomedicine and material sciences
Rüegg Curzio Roberto University of Fribourg - FR 01.05.2015 30.04.2016 R'EQUIP

Projects as project partner

Responsible applicant Institution of higher education Start End date Funding scheme

Bioinorganic Chemistry of Silver: Biomineralization, Silver Resistance, Antimicrobial Activity and more
Fromm Katharina M. University of Fribourg - FR 01.05.2018 30.04.2022 Project funding (Div. I-III)

Synergistic targeted drug combinations for induction of sensitivity to immune checkpoint inhibitors.
Nowak-Sliwinska Patrycja University of Geneva - GE 01.01.2021 31.12.2024 Project funding (Div. I-III)

-